Hanna Wacker

Associate, Corporate


Hanna Wacker focuses her practice on capital markets transactions as well as general securities-related matters.

Ms. Wacker’s experience at Skadden includes advising, among others:

Capital Markets (Equity)

  • Euronext Brussels and Euronext Amsterdam-listed ONWARD Medical, a leading developer of spinal cord injury therapies, in connection with a cash capital increase
  • Jefferies and BofA Securities as joint global coordinators and joint bookrunners in connection with capital increases of Zur Rose Group AG

Mergers and Acquisitions

  • the management and supervisory boards of Fresenius in the company’s exit from the Austrian and international businesses of VAMED AG
  • Armira and Boxine in Boxine’s €1 billion business combination with 468 SPAC I SE, one of the first de-SPAC transactions in the market involving a German-listed blanc cheque company
  • SIGNA Sports United GmbH in connection with its US$3.3 billion initial public offering on the New York Stock Exchange as a result of its de-SPAC merger with Yucaipa Acquisition Corporation. The merger also included the acquisition of WiggleCRC Group

Prior to joining Skadden’s Frankfurt office, Ms. Wacker worked as a research assistant and completed a legal clerkship in New York.



  • Second State Exam, Higher Regional Court of Frankfurt am Main, 2024
  • First State Exam, University of Dusseldorf, 2021


  • Not admitted in Germany


  • English
  • German

Hanna Wacker